Pramodini Medicare SME IPO GMP Today
Pramodini Medicare SME IPO opens on 12 August 2026. Pramodini Medicare SME IPO GMP is Rs 0.00 today. Listing price estimate is Rs 118.00 (issue price Rs 118.00).
Issue Price
Rs 118.00
GMP Today
Rs 0.00
GMP %
+0.00%
Listing Price
Rs 118.00
Listing Gain / Lot
Rs 0.00
Listing Date
19 Aug 2026
Pramodini Medicare SME IPO GMP Day Wise
GMP for Pramodini Medicare SME started at Rs 0 on 4 August 2026 and stood at Rs 0 on 6 August 2026. GMP typically moves more in the final two to three days before the close date, especially after QIB and HNI bids come in.
| Date | Issue Price | GMP | Listing Price | Estimated Profit |
|---|---|---|---|---|
| 6 Aug 2026Today | Rs 118.00 | Rs 0.00 | Rs 118.00 (+0.00%) | Rs 0.00 |
| 5 Aug 2026 | Rs 118.00 | Rs 0.00 | Rs 118.00 (+0.00%) | Rs 0.00 |
| 4 Aug 2026 | Rs 118.00 | Rs 0.00 | Rs 118.00 (+0.00%) | Rs 0.00 |
Pramodini Medicare SME IPO Listing Price
Based on today's GMP, Pramodini Medicare SME IPO listing price estimate is Rs 118.00 per share (issue price Rs 118.00 + GMP Rs 0.00).
Actual listing price will be known on 19 August 2026 when the stock lists on NSE/BSE.
Pramodini Medicare SME IPO Listing Gain
Lot size: 1200 shares (min. 2 lots for SME)
GMP today: Rs 0.00
Estimated listing gain per lot: Rs 0.00 × 2400 = Rs 0.00
Grey market activity is minimal or unavailable. GMP may appear once investor interest builds closer to the open date.
GMP is unofficial. Listing gain can differ on listing day.
Pramodini Medicare SME IPO Subscription Status
GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Pramodini Medicare SME is -. Compare this with the GMP trend to see if demand aligns.
See live figures on the Pramodini Medicare SME IPO Subscription Status page.
Pramodini Medicare SME IPO Details
| Field | Value |
|---|---|
| Price Band | ₹110.0 - ₹118.0 |
| Issue Size | ₹69.04 Cr |
| Lot Size | 1200 shares |
| IPO Type | NSE SME |
| Open Date | 12 Aug 2026 |
| Close Date | 14 Aug 2026 |
| Listing Date | 19 Aug 2026 |
| Subscription | - |
Pramodini Medicare SME IPO full details (financials, peers, review).
About Pramodini Medicare SME
No company information available
Pramodini Medicare SME IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Pramodini Medicare SME Details
Issue size, price, financials, and company info
Pramodini Medicare SME GMP
Live grey market premium and listing estimate
Pramodini Medicare SME Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Pramodini Medicare SME Allotment
Allotment date, chances, and check by PAN
Pramodini Medicare SME Review
SWOT, strengths, risks, and IPO review
Pramodini Medicare SME FAQ
Common questions on dates, GMP, and allotment
Pramodini Medicare SME Registrar
Registrar website and how to check allotment
Pramodini Medicare SME Timeline
Open, close, allotment, and listing dates
Pramodini Medicare SME News
Updates, blogs, and latest IPO news
Pramodini Medicare SME IPO GMP FAQs
What is Pramodini Medicare SME IPO GMP today?
Pramodini Medicare SME IPO GMP is not available yet. Grey market activity usually starts before the IPO opens. This page is updated when GMP data is available.
What is Pramodini Medicare SME IPO grey market premium (GMP)?
Grey market premium for Pramodini Medicare SME IPO is not live yet. GMP shows informal demand before the stock lists. It is not an exchange price.
What is Pramodini Medicare SME IPO expected returns?
Expected returns cannot be estimated until GMP data is available for Pramodini Medicare SME IPO.
What is the estimated listing price of Pramodini Medicare SME IPO?
Listing price estimate for Pramodini Medicare SME IPO will be added once grey market premium data is available.
What is the expected profit per lot in Pramodini Medicare SME IPO?
Profit per lot for Pramodini Medicare SME IPO depends on GMP and lot size. Check back when GMP is live.
Will Pramodini Medicare SME IPO list at GMP price?
It is too early to predict listing price for Pramodini Medicare SME IPO. Track GMP on this page as the subscription window progresses.
What is Pramodini Medicare SME IPO issue price and lot size?
Pramodini Medicare SME IPO issue price is ₹118 per share (price band ₹110.0 - ₹118.0). Lot size is 1200 shares. Minimum application is 2 lots for SME.
When is Pramodini Medicare SME IPO listing date?
Pramodini Medicare SME IPO is expected to list on 19 August 2026 on NSE and BSE. GMP can still move until listing day.
What is Pramodini Medicare SME IPO GMP high and low?
Pramodini Medicare SME IPO GMP made a high of ₹0 on 6 Aug 2026 and a low of ₹0 on 6 Aug 2026 in tracked grey market data.
Can Pramodini Medicare SME IPO GMP change after subscription closes?
Yes. Pramodini Medicare SME IPO closed on 14 August 2026. GMP often moves until listing (19 August 2026) based on allotment buzz, market mood, and news. Keep this page handy for the latest figure.
What is Pramodini Medicare SME IPO subscription status?
Live category-wise subscription for Pramodini Medicare SME IPO is on the Pramodini Medicare SME IPO Subscription Status page on IPOwiz, including QIB, NII, and retail figures.
How to check Pramodini Medicare SME IPO allotment status?
You can check Pramodini Medicare SME IPO allotment with your PAN on the Pramodini Medicare SME IPO Allotment Status page, the registrar site, BSE, or the IPOwiz App.
Sources
We match Pramodini Medicare SME IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews GMP figures before they go live.